Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the five brokerages that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have given a buy rating and one has assigned a strong buy rating […]
Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the five brokerages that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have given a buy rating and one has assigned a strong buy rating […]
